Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 138 | 2022 | 1548 | 11.070 |
Why?
|
Insulin Resistance | 91 | 2020 | 494 | 7.660 |
Why?
|
Atherosclerosis | 61 | 2021 | 718 | 5.900 |
Why?
|
African Americans | 79 | 2019 | 1522 | 4.180 |
Why?
|
Obesity | 45 | 2022 | 1081 | 3.550 |
Why?
|
Hispanic Americans | 59 | 2019 | 947 | 3.520 |
Why?
|
Insulin | 37 | 2020 | 363 | 3.150 |
Why?
|
Middle Aged | 213 | 2021 | 11167 | 3.130 |
Why?
|
Male | 243 | 2022 | 18050 | 2.950 |
Why?
|
Female | 243 | 2022 | 18308 | 2.950 |
Why?
|
Blood Glucose | 46 | 2021 | 483 | 2.890 |
Why?
|
Humans | 269 | 2022 | 29168 | 2.490 |
Why?
|
Polymorphism, Single Nucleotide | 54 | 2020 | 1241 | 2.440 |
Why?
|
Genome-Wide Association Study | 38 | 2021 | 618 | 2.380 |
Why?
|
Cardiovascular Diseases | 39 | 2020 | 1046 | 2.360 |
Why?
|
Aged | 139 | 2022 | 9602 | 2.290 |
Why?
|
Diabetes Mellitus | 16 | 2022 | 356 | 2.260 |
Why?
|
Cohort Studies | 55 | 2022 | 1709 | 2.230 |
Why?
|
European Continental Ancestry Group | 54 | 2019 | 1210 | 2.160 |
Why?
|
F2-Isoprostanes | 7 | 2017 | 22 | 2.150 |
Why?
|
Risk Factors | 90 | 2021 | 3550 | 2.070 |
Why?
|
Life Style | 23 | 2021 | 370 | 2.040 |
Why?
|
Carotid Artery Diseases | 11 | 2016 | 121 | 2.030 |
Why?
|
Genetic Predisposition to Disease | 35 | 2020 | 950 | 1.970 |
Why?
|
Adipose Tissue | 15 | 2018 | 334 | 1.850 |
Why?
|
Adiposity | 20 | 2017 | 208 | 1.820 |
Why?
|
Adult | 108 | 2020 | 8580 | 1.810 |
Why?
|
Weight Loss | 23 | 2021 | 411 | 1.750 |
Why?
|
Body Mass Index | 41 | 2020 | 887 | 1.640 |
Why?
|
Fatty Acids | 7 | 2020 | 94 | 1.640 |
Why?
|
Calcinosis | 11 | 2016 | 159 | 1.580 |
Why?
|
Membrane Proteins | 9 | 2019 | 269 | 1.440 |
Why?
|
Coronary Artery Disease | 13 | 2011 | 378 | 1.410 |
Why?
|
Albuminuria | 17 | 2017 | 209 | 1.410 |
Why?
|
Mexican Americans | 5 | 2019 | 64 | 1.380 |
Why?
|
Intra-Abdominal Fat | 8 | 2013 | 68 | 1.350 |
Why?
|
United States | 53 | 2021 | 3633 | 1.340 |
Why?
|
Lipase | 5 | 2019 | 29 | 1.290 |
Why?
|
Genetic Variation | 10 | 2019 | 284 | 1.250 |
Why?
|
Bone Density | 10 | 2018 | 191 | 1.230 |
Why?
|
Fasting | 17 | 2016 | 94 | 1.220 |
Why?
|
African Continental Ancestry Group | 25 | 2019 | 378 | 1.220 |
Why?
|
Arteriosclerosis | 18 | 2005 | 127 | 1.200 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2020 | 184 | 1.120 |
Why?
|
Fatty Liver | 6 | 2013 | 72 | 1.080 |
Why?
|
Weight Gain | 7 | 2016 | 106 | 1.060 |
Why?
|
Prospective Studies | 31 | 2022 | 1981 | 1.050 |
Why?
|
Overweight | 14 | 2021 | 256 | 1.040 |
Why?
|
Incidence | 31 | 2021 | 1097 | 1.030 |
Why?
|
Risk Assessment | 19 | 2021 | 1308 | 1.010 |
Why?
|
Genetic Loci | 11 | 2019 | 164 | 1.010 |
Why?
|
Lipids | 10 | 2019 | 219 | 1.000 |
Why?
|
Genome, Human | 10 | 2021 | 149 | 0.970 |
Why?
|
Follow-Up Studies | 36 | 2020 | 2130 | 0.970 |
Why?
|
Homeostasis | 10 | 2019 | 146 | 0.950 |
Why?
|
Diet | 9 | 2017 | 350 | 0.940 |
Why?
|
Vitamin D | 10 | 2018 | 174 | 0.930 |
Why?
|
Lipogenesis | 2 | 2020 | 19 | 0.920 |
Why?
|
Hypertension | 15 | 2017 | 980 | 0.910 |
Why?
|
Residence Characteristics | 3 | 2021 | 160 | 0.910 |
Why?
|
Adiponectin | 11 | 2017 | 117 | 0.900 |
Why?
|
Cross-Sectional Studies | 35 | 2021 | 1310 | 0.900 |
Why?
|
Glucose Tolerance Test | 24 | 2017 | 134 | 0.890 |
Why?
|
Genotype | 29 | 2020 | 826 | 0.890 |
Why?
|
Occupations | 2 | 2012 | 10 | 0.890 |
Why?
|
Alanine Transaminase | 5 | 2019 | 45 | 0.880 |
Why?
|
Aortic Diseases | 2 | 2016 | 57 | 0.880 |
Why?
|
Glucose Intolerance | 14 | 2013 | 44 | 0.870 |
Why?
|
Aged, 80 and over | 32 | 2021 | 3731 | 0.860 |
Why?
|
Prediabetic State | 8 | 2016 | 54 | 0.850 |
Why?
|
Diabetes Complications | 8 | 2018 | 184 | 0.850 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 49 | 0.850 |
Why?
|
Occupational Diseases | 2 | 2012 | 84 | 0.830 |
Why?
|
Prevalence | 16 | 2022 | 887 | 0.820 |
Why?
|
Aspartate Aminotransferases | 4 | 2019 | 28 | 0.810 |
Why?
|
Smoking | 8 | 2019 | 433 | 0.800 |
Why?
|
Triglycerides | 14 | 2020 | 222 | 0.780 |
Why?
|
Young Adult | 21 | 2020 | 2400 | 0.780 |
Why?
|
Aging | 7 | 2017 | 874 | 0.770 |
Why?
|
Cholesterol, HDL | 11 | 2019 | 173 | 0.770 |
Why?
|
Tomography, X-Ray Computed | 18 | 2017 | 890 | 0.770 |
Why?
|
Blood Pressure | 18 | 2017 | 874 | 0.760 |
Why?
|
Risk Reduction Behavior | 10 | 2018 | 111 | 0.720 |
Why?
|
Phenotype | 18 | 2020 | 676 | 0.710 |
Why?
|
Abdominal Fat | 5 | 2017 | 46 | 0.710 |
Why?
|
Coronary Vessels | 7 | 2017 | 160 | 0.700 |
Why?
|
Insulin-Secreting Cells | 9 | 2018 | 58 | 0.700 |
Why?
|
Disease Progression | 9 | 2016 | 594 | 0.680 |
Why?
|
Subcutaneous Fat | 4 | 2016 | 45 | 0.680 |
Why?
|
Abdomen | 4 | 2008 | 43 | 0.670 |
Why?
|
Nutrigenomics | 1 | 2017 | 2 | 0.670 |
Why?
|
Environment | 1 | 2017 | 49 | 0.650 |
Why?
|
Carotid Arteries | 7 | 2015 | 104 | 0.640 |
Why?
|
Metabolome | 4 | 2018 | 33 | 0.630 |
Why?
|
Alleles | 11 | 2021 | 276 | 0.630 |
Why?
|
Cognition Disorders | 4 | 2014 | 396 | 0.620 |
Why?
|
Heart Failure | 7 | 2018 | 575 | 0.610 |
Why?
|
Population Surveillance | 6 | 2021 | 116 | 0.600 |
Why?
|
Metabolic Clearance Rate | 3 | 2014 | 18 | 0.570 |
Why?
|
Diabetic Angiopathies | 11 | 2016 | 150 | 0.560 |
Why?
|
Physical Fitness | 4 | 2014 | 116 | 0.560 |
Why?
|
Adolescent | 20 | 2020 | 3242 | 0.560 |
Why?
|
Longitudinal Studies | 13 | 2019 | 705 | 0.560 |
Why?
|
Tunica Intima | 6 | 2014 | 67 | 0.550 |
Why?
|
Continental Population Groups | 5 | 2019 | 231 | 0.550 |
Why?
|
Time Factors | 18 | 2019 | 2007 | 0.540 |
Why?
|
Sleep | 2 | 2019 | 85 | 0.540 |
Why?
|
Patient Education as Topic | 6 | 2015 | 230 | 0.530 |
Why?
|
Ethnic Groups | 16 | 2020 | 452 | 0.520 |
Why?
|
Fatty Acids, Nonesterified | 2 | 2012 | 10 | 0.500 |
Why?
|
Minority Groups | 2 | 2011 | 63 | 0.490 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2015 | 170 | 0.490 |
Why?
|
Health | 1 | 2013 | 14 | 0.480 |
Why?
|
Quantitative Trait Loci | 10 | 2021 | 153 | 0.480 |
Why?
|
Lung | 2 | 2012 | 231 | 0.480 |
Why?
|
Waist Circumference | 8 | 2020 | 90 | 0.470 |
Why?
|
Plasminogen Activator Inhibitor 1 | 5 | 2017 | 47 | 0.460 |
Why?
|
DNA | 4 | 2009 | 214 | 0.440 |
Why?
|
Glucose | 7 | 2018 | 175 | 0.440 |
Why?
|
Cholesterol, LDL | 9 | 2019 | 167 | 0.440 |
Why?
|
Predictive Value of Tests | 15 | 2020 | 788 | 0.440 |
Why?
|
Vitamin D Deficiency | 5 | 2018 | 92 | 0.440 |
Why?
|
Respiratory Tract Diseases | 1 | 2012 | 30 | 0.430 |
Why?
|
Lung Diseases | 1 | 2012 | 46 | 0.430 |
Why?
|
Carotid Artery, Common | 4 | 2007 | 39 | 0.410 |
Why?
|
Oxidative Stress | 4 | 2017 | 254 | 0.390 |
Why?
|
Pedigree | 9 | 2014 | 150 | 0.390 |
Why?
|
Dietary Fats | 3 | 2018 | 109 | 0.390 |
Why?
|
Brain | 4 | 2019 | 949 | 0.390 |
Why?
|
Linear Models | 9 | 2019 | 429 | 0.390 |
Why?
|
Quantitative Trait, Heritable | 3 | 2021 | 51 | 0.390 |
Why?
|
Odds Ratio | 9 | 2019 | 457 | 0.380 |
Why?
|
Coronary Disease | 4 | 2017 | 207 | 0.370 |
Why?
|
Contrast Media | 2 | 2011 | 125 | 0.370 |
Why?
|
Liver | 6 | 2019 | 470 | 0.370 |
Why?
|
Motor Activity | 4 | 2015 | 305 | 0.370 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2021 | 47 | 0.370 |
Why?
|
Polymorphism, Genetic | 3 | 2008 | 215 | 0.360 |
Why?
|
Family | 8 | 2018 | 121 | 0.360 |
Why?
|
Texas | 9 | 2014 | 41 | 0.360 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 65 | 0.360 |
Why?
|
Gene Frequency | 8 | 2019 | 274 | 0.360 |
Why?
|
Lipid Metabolism | 3 | 2019 | 103 | 0.360 |
Why?
|
Aorta, Abdominal | 3 | 2007 | 29 | 0.350 |
Why?
|
Forecasting | 4 | 2019 | 132 | 0.350 |
Why?
|
Risk | 9 | 2018 | 295 | 0.350 |
Why?
|
Age Factors | 7 | 2020 | 1105 | 0.350 |
Why?
|
Dairy Products | 3 | 2018 | 12 | 0.340 |
Why?
|
Case-Control Studies | 8 | 2019 | 912 | 0.340 |
Why?
|
Exercise | 6 | 2019 | 563 | 0.330 |
Why?
|
Linkage Disequilibrium | 8 | 2019 | 222 | 0.320 |
Why?
|
Stroke | 4 | 2017 | 507 | 0.310 |
Why?
|
Regression Analysis | 8 | 2017 | 275 | 0.310 |
Why?
|
C-Reactive Protein | 9 | 2016 | 238 | 0.310 |
Why?
|
Colorado | 7 | 2014 | 45 | 0.310 |
Why?
|
Islets of Langerhans | 5 | 2016 | 73 | 0.310 |
Why?
|
Radiography | 4 | 2013 | 359 | 0.310 |
Why?
|
Amyloid | 2 | 2017 | 16 | 0.310 |
Why?
|
Lymphotoxin-alpha | 1 | 2006 | 5 | 0.300 |
Why?
|
Sex Factors | 10 | 2019 | 635 | 0.300 |
Why?
|
Fibroblast Growth Factors | 2 | 2017 | 36 | 0.300 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 159 | 0.300 |
Why?
|
Proteins | 3 | 2019 | 145 | 0.290 |
Why?
|
Depression | 2 | 2022 | 351 | 0.290 |
Why?
|
Anthropometry | 5 | 2017 | 83 | 0.290 |
Why?
|
Hormone Replacement Therapy | 2 | 2007 | 88 | 0.280 |
Why?
|
Diabetic Nephropathies | 5 | 2016 | 246 | 0.280 |
Why?
|
Prognosis | 7 | 2020 | 1447 | 0.280 |
Why?
|
Inflammation | 5 | 2017 | 510 | 0.270 |
Why?
|
Logistic Models | 8 | 2019 | 724 | 0.270 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2004 | 26 | 0.260 |
Why?
|
Postmenopause | 3 | 2007 | 396 | 0.260 |
Why?
|
Heart | 3 | 2020 | 179 | 0.260 |
Why?
|
Obesity, Abdominal | 2 | 2017 | 24 | 0.260 |
Why?
|
Apolipoproteins | 4 | 2014 | 219 | 0.250 |
Why?
|
Tandem Mass Spectrometry | 3 | 2015 | 56 | 0.250 |
Why?
|
Indians, North American | 2 | 2020 | 112 | 0.250 |
Why?
|
Genetic Association Studies | 8 | 2015 | 171 | 0.250 |
Why?
|
Ultrasonography | 6 | 2021 | 352 | 0.250 |
Why?
|
Body Fat Distribution | 3 | 2019 | 37 | 0.240 |
Why?
|
Chromosome Mapping | 6 | 2019 | 213 | 0.240 |
Why?
|
Health Surveys | 2 | 2017 | 188 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 204 | 0.240 |
Why?
|
Lod Score | 8 | 2017 | 86 | 0.240 |
Why?
|
Atrial Fibrillation | 2 | 2019 | 313 | 0.230 |
Why?
|
Medicare | 1 | 2004 | 177 | 0.230 |
Why?
|
Sex Characteristics | 6 | 2016 | 174 | 0.230 |
Why?
|
Multivariate Analysis | 7 | 2019 | 646 | 0.230 |
Why?
|
Proportional Hazards Models | 7 | 2018 | 722 | 0.230 |
Why?
|
Body Composition | 3 | 2015 | 367 | 0.220 |
Why?
|
Life Change Events | 1 | 2022 | 21 | 0.220 |
Why?
|
gamma-Glutamyltransferase | 2 | 2019 | 9 | 0.220 |
Why?
|
Myocardial Infarction | 3 | 2018 | 411 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 73 | 0.220 |
Why?
|
Loneliness | 1 | 2022 | 6 | 0.220 |
Why?
|
Cough | 2 | 2012 | 19 | 0.220 |
Why?
|
Fibrinogen | 5 | 2017 | 42 | 0.220 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2017 | 109 | 0.210 |
Why?
|
Comorbidity | 4 | 2016 | 546 | 0.210 |
Why?
|
Organ Size | 3 | 2019 | 208 | 0.210 |
Why?
|
Pericardium | 3 | 2010 | 53 | 0.210 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 1223 | 0.210 |
Why?
|
Family Health | 6 | 2011 | 86 | 0.210 |
Why?
|
Lipoproteins | 3 | 2013 | 82 | 0.200 |
Why?
|
Glomerular Filtration Rate | 6 | 2017 | 309 | 0.200 |
Why?
|
Epistasis, Genetic | 2 | 2018 | 50 | 0.200 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2019 | 19 | 0.200 |
Why?
|
North Carolina | 8 | 2019 | 1407 | 0.200 |
Why?
|
Child | 5 | 2020 | 2174 | 0.200 |
Why?
|
Receptor, Melatonin, MT2 | 2 | 2018 | 5 | 0.200 |
Why?
|
Cardiology | 1 | 2021 | 72 | 0.200 |
Why?
|
Positron-Emission Tomography | 5 | 2020 | 178 | 0.190 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2020 | 11 | 0.190 |
Why?
|
Autonomic Nervous System | 1 | 2020 | 42 | 0.190 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2018 | 4 | 0.190 |
Why?
|
Diet Records | 2 | 2017 | 31 | 0.190 |
Why?
|
Spine | 2 | 2018 | 43 | 0.190 |
Why?
|
Phylogeny | 1 | 2019 | 59 | 0.190 |
Why?
|
Periodicals as Topic | 1 | 2021 | 96 | 0.190 |
Why?
|
Apolipoprotein E4 | 2 | 2018 | 58 | 0.190 |
Why?
|
Severity of Illness Index | 4 | 2015 | 870 | 0.190 |
Why?
|
Eicosanoic Acids | 1 | 2019 | 1 | 0.180 |
Why?
|
Infant | 2 | 2020 | 948 | 0.180 |
Why?
|
Electronic Health Records | 1 | 2020 | 114 | 0.180 |
Why?
|
Kidney Diseases | 3 | 2014 | 255 | 0.180 |
Why?
|
Proinsulin | 3 | 2011 | 9 | 0.180 |
Why?
|
HLA-D Antigens | 1 | 2019 | 1 | 0.180 |
Why?
|
Reproducibility of Results | 5 | 2017 | 705 | 0.180 |
Why?
|
Diet, Reducing | 3 | 2015 | 90 | 0.180 |
Why?
|
Heart Ventricles | 1 | 2019 | 117 | 0.170 |
Why?
|
Body Weight | 2 | 2011 | 297 | 0.170 |
Why?
|
Child, Preschool | 2 | 2020 | 1170 | 0.170 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 378 | 0.170 |
Why?
|
Mass Screening | 1 | 2020 | 204 | 0.170 |
Why?
|
Dementia | 2 | 2018 | 225 | 0.170 |
Why?
|
Genetic Testing | 1 | 2019 | 95 | 0.170 |
Why?
|
Calcium-Binding Proteins | 2 | 2019 | 47 | 0.170 |
Why?
|
Asthma | 2 | 2012 | 386 | 0.170 |
Why?
|
Life Expectancy | 1 | 2018 | 16 | 0.170 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 202 | 0.170 |
Why?
|
Heart Rate | 1 | 2020 | 330 | 0.170 |
Why?
|
Alcohol Drinking | 2 | 2019 | 231 | 0.160 |
Why?
|
Infant, Newborn | 1 | 2020 | 581 | 0.160 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2017 | 31 | 0.160 |
Why?
|
Vitamin D-Binding Protein | 2 | 2015 | 12 | 0.160 |
Why?
|
Disabled Persons | 1 | 2018 | 78 | 0.160 |
Why?
|
Waist-Hip Ratio | 3 | 2019 | 39 | 0.160 |
Why?
|
Pilot Projects | 2 | 2011 | 458 | 0.160 |
Why?
|
Cardiovascular System | 1 | 2017 | 41 | 0.160 |
Why?
|
Frail Elderly | 1 | 2017 | 59 | 0.150 |
Why?
|
Ventricular Premature Complexes | 1 | 2017 | 12 | 0.150 |
Why?
|
Microsatellite Repeats | 2 | 2014 | 30 | 0.150 |
Why?
|
Atrial Premature Complexes | 1 | 2017 | 15 | 0.150 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 13 | 0.150 |
Why?
|
Laminin | 1 | 2016 | 14 | 0.150 |
Why?
|
Amino Acids | 1 | 2016 | 40 | 0.150 |
Why?
|
Haplotypes | 4 | 2019 | 254 | 0.150 |
Why?
|
Lipoproteins, HDL | 3 | 2014 | 271 | 0.150 |
Why?
|
C-Peptide | 2 | 2017 | 26 | 0.150 |
Why?
|
Creatinine | 6 | 2017 | 185 | 0.150 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 39 | 0.140 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 7 | 0.140 |
Why?
|
Retrospective Studies | 5 | 2017 | 3117 | 0.140 |
Why?
|
Activities of Daily Living | 1 | 2017 | 213 | 0.140 |
Why?
|
Treatment Outcome | 5 | 2016 | 3111 | 0.140 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2015 | 3 | 0.140 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2016 | 56 | 0.140 |
Why?
|
Quality of Life | 1 | 2021 | 793 | 0.140 |
Why?
|
Research Design | 3 | 2019 | 270 | 0.140 |
Why?
|
Fractures, Bone | 1 | 2017 | 141 | 0.140 |
Why?
|
Signal Transduction | 1 | 2019 | 695 | 0.140 |
Why?
|
Stress, Physiological | 1 | 2015 | 45 | 0.140 |
Why?
|
Energy Metabolism | 2 | 2018 | 140 | 0.130 |
Why?
|
Sex Distribution | 3 | 2017 | 189 | 0.130 |
Why?
|
Genome | 1 | 2014 | 43 | 0.130 |
Why?
|
Chronic Disease | 2 | 2017 | 372 | 0.130 |
Why?
|
Hippocampus | 1 | 2016 | 187 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 68 | 0.130 |
Why?
|
Mutant Chimeric Proteins | 1 | 2014 | 6 | 0.130 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 8 | 0.130 |
Why?
|
HMGA2 Protein | 1 | 2014 | 15 | 0.130 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2014 | 11 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 13 | 0.130 |
Why?
|
Geriatric Assessment | 1 | 2017 | 325 | 0.130 |
Why?
|
Health Status | 1 | 2017 | 357 | 0.130 |
Why?
|
Atrial Function, Left | 1 | 2014 | 18 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 31 | 0.130 |
Why?
|
Glucose Clamp Technique | 1 | 2014 | 13 | 0.130 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2014 | 4 | 0.130 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 7 | 0.130 |
Why?
|
Models, Biological | 4 | 2011 | 377 | 0.130 |
Why?
|
Feeding Behavior | 2 | 2013 | 160 | 0.130 |
Why?
|
Ethylene Glycols | 3 | 2019 | 8 | 0.130 |
Why?
|
Neoplasms | 1 | 2020 | 608 | 0.120 |
Why?
|
Heart Atria | 1 | 2014 | 65 | 0.120 |
Why?
|
Aniline Compounds | 3 | 2019 | 25 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 26 | 0.120 |
Why?
|
Eggs | 1 | 2013 | 4 | 0.120 |
Why?
|
Energy Intake | 2 | 2012 | 122 | 0.120 |
Why?
|
Databases, Factual | 1 | 2014 | 330 | 0.120 |
Why?
|
Inpatients | 1 | 2013 | 53 | 0.120 |
Why?
|
Heart Diseases | 1 | 2014 | 101 | 0.120 |
Why?
|
Cholesterol, Dietary | 1 | 2013 | 37 | 0.120 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2013 | 36 | 0.120 |
Why?
|
Body Constitution | 4 | 2005 | 27 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 271 | 0.120 |
Why?
|
Demography | 4 | 2016 | 110 | 0.120 |
Why?
|
Apolipoproteins B | 3 | 2013 | 44 | 0.110 |
Why?
|
Counseling | 1 | 2012 | 79 | 0.110 |
Why?
|
Data Collection | 2 | 2010 | 162 | 0.110 |
Why?
|
Bronchitis, Chronic | 1 | 2012 | 2 | 0.110 |
Why?
|
Models, Statistical | 2 | 2014 | 156 | 0.110 |
Why?
|
Dyslipidemias | 2 | 2013 | 52 | 0.110 |
Why?
|
Bronchitis | 1 | 2012 | 2 | 0.110 |
Why?
|
Respiratory Sounds | 1 | 2012 | 10 | 0.110 |
Why?
|
Lipid Peroxidation | 2 | 2017 | 36 | 0.110 |
Why?
|
Spirometry | 1 | 2012 | 32 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2012 | 30 | 0.110 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 110 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 105 | 0.110 |
Why?
|
Peptide Fragments | 2 | 2016 | 486 | 0.110 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 496 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2011 | 40 | 0.110 |
Why?
|
Hospitalization | 2 | 2016 | 397 | 0.110 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 223 | 0.100 |
Why?
|
Hypercholesterolemia | 2 | 2017 | 59 | 0.100 |
Why?
|
Integrin beta3 | 1 | 2011 | 10 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 177 | 0.100 |
Why?
|
Survival Analysis | 2 | 2020 | 462 | 0.100 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2011 | 31 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2011 | 12 | 0.100 |
Why?
|
RGS Proteins | 1 | 2011 | 19 | 0.100 |
Why?
|
Coffee | 1 | 2010 | 10 | 0.100 |
Why?
|
Caloric Restriction | 2 | 2015 | 92 | 0.100 |
Why?
|
Eating | 1 | 2011 | 74 | 0.100 |
Why?
|
Food Preferences | 1 | 2011 | 36 | 0.100 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 167 | 0.100 |
Why?
|
Caffeine | 1 | 2010 | 31 | 0.100 |
Why?
|
Echocardiography | 3 | 2019 | 143 | 0.100 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2010 | 34 | 0.100 |
Why?
|
Internationality | 1 | 2010 | 22 | 0.100 |
Why?
|
Transcription Factors | 3 | 2019 | 194 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2010 | 8 | 0.100 |
Why?
|
P-Selectin | 2 | 2011 | 11 | 0.100 |
Why?
|
Genetic Markers | 4 | 2013 | 135 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2009 | 13 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2011 | 100 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 302 | 0.090 |
Why?
|
Statistics as Topic | 3 | 2017 | 106 | 0.090 |
Why?
|
Southwestern United States | 1 | 2009 | 3 | 0.090 |
Why?
|
Asian Americans | 2 | 2013 | 99 | 0.090 |
Why?
|
Europe | 3 | 2018 | 83 | 0.090 |
Why?
|
Tunica Media | 2 | 2014 | 33 | 0.090 |
Why?
|
Fibrosis | 1 | 2009 | 113 | 0.090 |
Why?
|
Minnesota | 2 | 2019 | 18 | 0.090 |
Why?
|
Morbidity | 2 | 2020 | 89 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2006 | 132 | 0.090 |
Why?
|
Fluorine Radioisotopes | 2 | 2019 | 21 | 0.090 |
Why?
|
Spleen | 1 | 2009 | 83 | 0.090 |
Why?
|
Exercise Test | 3 | 2017 | 190 | 0.090 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 17 | 0.080 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2008 | 7 | 0.080 |
Why?
|
Peripheral Vascular Diseases | 1 | 2008 | 35 | 0.080 |
Why?
|
Calcitriol | 1 | 2008 | 24 | 0.080 |
Why?
|
Epidemiologic Methods | 2 | 2005 | 23 | 0.080 |
Why?
|
Behavior Therapy | 3 | 2015 | 89 | 0.080 |
Why?
|
Brachial Artery | 1 | 2008 | 66 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2006 | 39 | 0.080 |
Why?
|
Pain | 1 | 2010 | 276 | 0.080 |
Why?
|
Dietary Fiber | 1 | 2007 | 19 | 0.080 |
Why?
|
Asian Continental Ancestry Group | 2 | 2019 | 115 | 0.080 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 2018 | 9 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 356 | 0.080 |
Why?
|
Lipoprotein Lipase | 1 | 2006 | 14 | 0.080 |
Why?
|
Uric Acid | 1 | 2006 | 24 | 0.080 |
Why?
|
California | 2 | 2004 | 61 | 0.080 |
Why?
|
Kidney Function Tests | 2 | 2017 | 108 | 0.070 |
Why?
|
Algorithms | 3 | 2020 | 468 | 0.070 |
Why?
|
Metabolomics | 2 | 2018 | 45 | 0.070 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 29 | 0.070 |
Why?
|
CD40 Ligand | 1 | 2006 | 14 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2019 | 122 | 0.070 |
Why?
|
Cardiopulmonary Bypass | 1 | 2005 | 56 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2005 | 36 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 153 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2005 | 82 | 0.070 |
Why?
|
Genome Components | 1 | 2005 | 3 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 80 | 0.070 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 13 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 34 | 0.070 |
Why?
|
Health Behavior | 3 | 2014 | 213 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 101 | 0.070 |
Why?
|
Progesterone | 1 | 2005 | 80 | 0.070 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 37 | 0.070 |
Why?
|
Mental Disorders | 1 | 2005 | 97 | 0.070 |
Why?
|
Educational Status | 2 | 2016 | 153 | 0.070 |
Why?
|
Leptin | 2 | 2016 | 67 | 0.070 |
Why?
|
Electrocardiography | 3 | 2018 | 564 | 0.060 |
Why?
|
Principal Component Analysis | 2 | 2017 | 61 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2004 | 29 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 147 | 0.060 |
Why?
|
Cholesterol Ester Transfer Proteins | 2 | 2014 | 12 | 0.060 |
Why?
|
Estrogen Replacement Therapy | 1 | 2005 | 183 | 0.060 |
Why?
|
Survival Rate | 2 | 2019 | 824 | 0.060 |
Why?
|
Models, Genetic | 2 | 2018 | 102 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2004 | 57 | 0.060 |
Why?
|
Kidney | 1 | 2007 | 499 | 0.060 |
Why?
|
Lipoproteins, LDL | 1 | 2003 | 77 | 0.060 |
Why?
|
Cognition | 2 | 2018 | 527 | 0.060 |
Why?
|
Heterozygote | 2 | 2014 | 54 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 535 | 0.060 |
Why?
|
Apolipoproteins E | 2 | 2017 | 101 | 0.060 |
Why?
|
Reference Values | 3 | 2008 | 230 | 0.060 |
Why?
|
Exons | 2 | 2016 | 57 | 0.050 |
Why?
|
Exercise Therapy | 2 | 2015 | 195 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 96 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2016 | 127 | 0.050 |
Why?
|
Physical Chromosome Mapping | 1 | 2021 | 8 | 0.050 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 20 | 0.050 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 17 | 0.050 |
Why?
|
Absorptiometry, Photon | 2 | 2015 | 130 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 101 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 23 | 0.050 |
Why?
|
Age of Onset | 1 | 2020 | 98 | 0.050 |
Why?
|
Diabetic Neuropathies | 2 | 2007 | 23 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 40 | 0.050 |
Why?
|
Cerebral Angiography | 1 | 2020 | 51 | 0.050 |
Why?
|
Treatment Failure | 2 | 2013 | 165 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2019 | 7 | 0.050 |
Why?
|
Brazil | 1 | 2019 | 14 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 543 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2019 | 36 | 0.040 |
Why?
|
Taiwan | 1 | 2018 | 8 | 0.040 |
Why?
|
Australia | 1 | 2018 | 29 | 0.040 |
Why?
|
Drosophila | 1 | 2019 | 37 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2019 | 62 | 0.040 |
Why?
|
Homozygote | 2 | 2011 | 62 | 0.040 |
Why?
|
Erythritol | 1 | 2018 | 1 | 0.040 |
Why?
|
Trehalose | 1 | 2018 | 3 | 0.040 |
Why?
|
Isoleucine | 1 | 2018 | 8 | 0.040 |
Why?
|
Asparagine | 1 | 2018 | 6 | 0.040 |
Why?
|
Mississippi | 1 | 2018 | 23 | 0.040 |
Why?
|
Maryland | 1 | 2018 | 26 | 0.040 |
Why?
|
Valine | 1 | 2018 | 27 | 0.040 |
Why?
|
Leucine | 1 | 2018 | 30 | 0.040 |
Why?
|
Lactic Acid | 1 | 2018 | 53 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2017 | 14 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2017 | 39 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 50 | 0.040 |
Why?
|
ROC Curve | 2 | 2011 | 149 | 0.040 |
Why?
|
Cholesterol | 1 | 2019 | 233 | 0.040 |
Why?
|
Health Education | 1 | 2018 | 119 | 0.040 |
Why?
|
Puerto Rico | 1 | 2016 | 11 | 0.040 |
Why?
|
Gait | 1 | 2017 | 87 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2016 | 24 | 0.040 |
Why?
|
Public Health | 1 | 2017 | 68 | 0.040 |
Why?
|
Walking | 1 | 2017 | 155 | 0.040 |
Why?
|
Independent Living | 1 | 2017 | 58 | 0.040 |
Why?
|
Fructosamine | 1 | 2016 | 5 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2016 | 5 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 18 | 0.040 |
Why?
|
Introns | 1 | 2016 | 48 | 0.040 |
Why?
|
Los Angeles | 2 | 2008 | 9 | 0.040 |
Why?
|
Computational Biology | 1 | 2017 | 89 | 0.040 |
Why?
|
Cystatin C | 1 | 2016 | 30 | 0.040 |
Why?
|
Calcium | 2 | 2010 | 305 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 95 | 0.040 |
Why?
|
Serum Albumin | 1 | 2016 | 53 | 0.040 |
Why?
|
Phosphates | 1 | 2015 | 26 | 0.040 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2015 | 13 | 0.040 |
Why?
|
Iliac Artery | 1 | 2015 | 47 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2006 | 97 | 0.040 |
Why?
|
Troponin T | 1 | 2016 | 55 | 0.040 |
Why?
|
Microvessels | 1 | 2015 | 27 | 0.040 |
Why?
|
Factor XIII | 1 | 2015 | 3 | 0.040 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 5 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2015 | 20 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2015 | 40 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 6 | 0.030 |
Why?
|
Carnitine | 1 | 2015 | 10 | 0.030 |
Why?
|
Ultrasonography, Interventional | 2 | 2007 | 51 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 8 | 0.030 |
Why?
|
Propensity Score | 1 | 2014 | 32 | 0.030 |
Why?
|
Animals | 2 | 2019 | 7435 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 51 | 0.030 |
Why?
|
Recurrence | 1 | 2015 | 240 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
Metabolic Equivalent | 1 | 2014 | 3 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 249 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2014 | 24 | 0.030 |
Why?
|
Physical Exertion | 1 | 2014 | 13 | 0.030 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 3 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 63 | 0.030 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 1 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 8 | 0.030 |
Why?
|
Lysophospholipase | 1 | 2013 | 5 | 0.030 |
Why?
|
Genomics | 1 | 2014 | 87 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2013 | 12 | 0.030 |
Why?
|
Factor Analysis, Statistical | 2 | 2004 | 68 | 0.030 |
Why?
|
Cause of Death | 1 | 2014 | 224 | 0.030 |
Why?
|
Oceanic Ancestry Group | 1 | 2013 | 6 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 247 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2017 | 300 | 0.030 |
Why?
|
Bone Resorption | 1 | 2013 | 14 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2013 | 60 | 0.030 |
Why?
|
Fatty Acid Desaturases | 1 | 2013 | 48 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2012 | 20 | 0.030 |
Why?
|
Psychotherapy, Group | 1 | 2012 | 15 | 0.030 |
Why?
|
Remission Induction | 1 | 2012 | 84 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 383 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2012 | 41 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2013 | 187 | 0.030 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2012 | 1 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 14 | 0.030 |
Why?
|
Diet Surveys | 1 | 2012 | 56 | 0.030 |
Why?
|
Dietary Proteins | 1 | 2012 | 50 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2012 | 103 | 0.030 |
Why?
|
Asia | 1 | 2011 | 16 | 0.030 |
Why?
|
Africa | 1 | 2011 | 24 | 0.030 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 3 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2011 | 4 | 0.030 |
Why?
|
Social Support | 1 | 2012 | 150 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 17 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 21 | 0.030 |
Why?
|
Systole | 1 | 2011 | 90 | 0.030 |
Why?
|
Phosphorus | 1 | 2010 | 12 | 0.030 |
Why?
|
Diastole | 1 | 2011 | 97 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 158 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 80 | 0.020 |
Why?
|
Quality Control | 1 | 2010 | 41 | 0.020 |
Why?
|
Knee | 1 | 2010 | 31 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2011 | 192 | 0.020 |
Why?
|
Government Regulation | 1 | 2010 | 36 | 0.020 |
Why?
|
Base Sequence | 1 | 2010 | 251 | 0.020 |
Why?
|
Program Development | 1 | 2010 | 82 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 68 | 0.020 |
Why?
|
Aorta | 1 | 2010 | 113 | 0.020 |
Why?
|
Skinfold Thickness | 1 | 2009 | 7 | 0.020 |
Why?
|
Mortality | 1 | 2010 | 108 | 0.020 |
Why?
|
Body Size | 1 | 2009 | 31 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2009 | 140 | 0.020 |
Why?
|
Mice | 1 | 2015 | 2397 | 0.020 |
Why?
|
Seasons | 1 | 2009 | 84 | 0.020 |
Why?
|
Gene Expression | 1 | 2010 | 347 | 0.020 |
Why?
|
Urban Population | 1 | 2009 | 77 | 0.020 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2008 | 6 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2008 | 11 | 0.020 |
Why?
|
Ankle Joint | 1 | 2008 | 30 | 0.020 |
Why?
|
Apolipoprotein A-I | 1 | 2008 | 68 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2008 | 20 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2008 | 19 | 0.020 |
Why?
|
Markov Chains | 1 | 2008 | 26 | 0.020 |
Why?
|
Rural Population | 1 | 2009 | 229 | 0.020 |
Why?
|
Observation | 1 | 2007 | 23 | 0.020 |
Why?
|
Carotid Artery, Internal | 1 | 2007 | 29 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2006 | 15 | 0.020 |
Why?
|
Estrogens | 1 | 2007 | 171 | 0.020 |
Why?
|
Self Care | 1 | 2007 | 129 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2005 | 36 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2006 | 132 | 0.020 |
Why?
|
Lipoproteins, VLDL | 1 | 2005 | 27 | 0.020 |
Why?
|
Albumins | 1 | 2005 | 38 | 0.020 |
Why?
|
Threonine | 1 | 2005 | 12 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2005 | 14 | 0.020 |
Why?
|
Viscera | 1 | 2005 | 18 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2005 | 42 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2004 | 19 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2005 | 48 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2004 | 137 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2005 | 507 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 135 | 0.020 |
Why?
|
Hyperinsulinism | 1 | 2003 | 12 | 0.020 |
Why?
|
Thrombophilia | 1 | 2003 | 8 | 0.020 |
Why?
|
Cysteine | 1 | 2005 | 130 | 0.020 |
Why?
|
World Health Organization | 1 | 2003 | 21 | 0.020 |
Why?
|
Health Promotion | 1 | 2006 | 209 | 0.020 |
Why?
|
Blood Proteins | 1 | 2003 | 21 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 455 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2005 | 219 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2004 | 461 | 0.020 |
Why?
|
Mexico | 1 | 2003 | 64 | 0.010 |
Why?
|
Area Under Curve | 1 | 2003 | 82 | 0.010 |
Why?
|
Age Distribution | 1 | 2002 | 200 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 582 | 0.010 |
Why?
|
Vascular Diseases | 1 | 1992 | 62 | 0.010 |
Why?
|
Diabetic Retinopathy | 1 | 1992 | 69 | 0.010 |
Why?
|
Education | 1 | 1989 | 30 | 0.010 |
Why?
|